Home Shop SCREEN-WELL® Hepatotoxicity library

SCREEN-WELL^® Hepatotoxicity library

BML-2851

Datasheet
Manual
SDS
CofA

Already have an account?

Essential standards for predictive toxicology screening

The SCREEN-WELL^® Hepatotoxicity Library is a focused collection of 238 compounds with defined and diverse hepatotoxicity, including steatosis, mitochondrial toxicity, Mallory body formation, cholestatic effects, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Product Details

Application	HTS
Concentration	DMSO solutions (10mM).
Contents	238 compounds with defined and diverse hepatotoxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
Quantity	100 µl/well or 500 µl/well
Technical Info / Product Notes	Application Note (Predictive Toxicology Application): Predictive High-Content/High-Throughput Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell (iPSC)-Derived Hepatocytes. Three Dimensional Hepatotoxicity Screening using Corning® HepatoCells, the Spheroid Microplate, and the SCREEN-WELL® Hepatotoxicity Library.

Handling & Storage

Use/Stability	As indicated on product label or CoA when stored as recommended. Stable for at least one year from the date of receipt when stored at -80°C.
Handling	Avoid freeze/thaw cycles.
Long Term Storage	-80°C
Shipping	Dry Ice

Regulatory Status	RUO – Research Use Only

A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®: K.M. Bircsak, et al.; Toxicology 450, 152667 (2021), Abstract
High-fidelity drug-induced liver injury screen using human pluripotent stem cell–derived organoids: T. Shinozawa, et al.; Gastroenterology. 160, 831 (2021), Abstract — Full Text
Live‐cell screening platform using human‐induced pluripotent stem cells expressing fluorescence‐tagged cytochrome P450 1A1: J.W. Kim, et al.; FASEB J. 34, 9141 (2020), Abstract
Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury: M.T. Donato, et al.; Differentiation 106, 15 (2019), Abstract
The convergence of stem cell technologies and phenotypic drug discovery: A. Friese, et al.; Cell Chem. Biol. 26, 1050 (2019), Abstract
High-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell-Derived Cells: O. Sirenko, et al.; Assay Drug Dev. Technol. 12, 43 (2014), Abstract — Full Text

Last modified: May 29, 2024

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Datasheet

Certificate of Analysis

Please enter the lot number as featured on the product label

Lot No. :

SDS

Enzo Life Science provides GHS Compliant SDS

If your language is not available please fill out the SDS request form

Your Cart

Your Cart

SCREEN-WELL^® Hepatotoxicity library

BML-2851

Product Details

Handling & Storage

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Certificate of Analysis

SDS

Change Country

Tell us about You

Tell us about your paper

Tell us about You

Tell us about your project